Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aundrietta D Duncan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|May 19, 2017
Sample Preparation for Mass Cytometry AnalysisRyan L McCarthy, Aundrietta D Duncan, Michelle C Barton
Molecular and Cellular Biology|May 14, 2014
TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damageAbhinav K Jain, Kendra Allton, Aundrietta D Duncan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
Nature Communications|September 11, 2021
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancerVrutant V Shah, Aundrietta D Duncan, Shiming Jiang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|May 19, 2017
Sample Preparation for Mass Cytometry AnalysisRyan L McCarthy, Aundrietta D Duncan, Michelle C Barton
Molecular and Cellular Biology|May 14, 2014
TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damageAbhinav K Jain, Kendra Allton, Aundrietta D Duncan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
Nature Communications|September 11, 2021
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancerVrutant V Shah, Aundrietta D Duncan, Shiming Jiang, et al.
Pageof 1